About 67 results
Apr 25, 2013
Discriminating metabolite patterns for various toxicological modes of action (“MoA”s) were developed from the metabolite profiles in the MetaMap Tox database for over 500 compounds as described in van Ravenzwaay et al., ...
Jan 5, 2010 by Rosenbeck, L. L, Srivastava, S., Kiel, P. J
Time to recover an absolute neutrophil count (ANC) greater than or equal to 0.5 × 109/L was significantly shorter in patients randomized to PBSC transplantation (median 11 vs 14 days; p = 0.005). ... Narayanasami et al.44 randomized patients
with relapsed or refractory NHL or HD to receive G-CSF 10 μg/kg/day (n = 23) or cyclophosphamide 5 g/m2 with G-CSF 10 μg/kg/day (n = 24) for mobilization of PBSCs for autologous rescue. ...... Thousand Oaks, CA: Amgen Inc., 1991–1996. ↵.
Apr 2, 2013 by Shuling Guo, Carla Casu, Sara Gardenghi, Sheri Booten, Mariam Aghajan, Raechel Peralta, Andy Watt, Sue Freier, Brett P. Monia, Stefano Rivella
Thalassemic animals (th3/+) show normal to increased expression of Id1, Atoh8, Smad7, and Bmp6 (some differences are seen in males vs. females), although these levels are inappropriately low relative to LIC (32, 34, 35). th3/+ .... levels of iron
in their liver, while in our experimental model the LIC values were in the normal range; it could also be due to the difference in genetic background (C57BL/6 background in this study and mixed background in Nai et al.; ref.
Jun 7, 2013 by Patent Blast
1. P S Products et. al. v. Activision Blizzard et. al. ... Method of scrolling window screen by means of controlling electronic by Lin et. al. ... 6. Zenith Electronics et. al. v. Viewsonic ... Presided by: Edgardo Ramos. Civil Action No: 7:13-cv-03767-ER.
Defendant(s) : 1. Viatek Consumer Products Group, Inc. Plaintiff(s) : Radiancy, Inc. — represented by. Proskauer Rose LLP; New York, NY. Attorneys: Steven Michael Kayman, ..... Bayer HealthCare Pharmaceuticals Inc.
Oct 1, 2012 by jrlatham
Even threats of physical violence have been used, most recently against Andres Carrasco, Professor of Molecular Embryology at the University of Buenos Aires, whose research (Paganelli et al. .... State University, USA); Dr Paulo Roberto Matins
, Coordinator of the Brazilian Research Network in Nanotechnology, Society and Environment); Paulo Cezar Mendes Ramos (PhD ICMBio - Chico Mendes Biodiversity Conservation Institute, Brazil); Henry Kuska (PhD ret.
Sep 12, 2013 by Peter Phillips
Laurence Fink, US, CB- PNC Financial Services Group Inc., Innovir Laboratories Inc., York Stock Exchange, Inc., PE-The First Boston Corporation, VIMRx Pharmaceuticals Inc., E-University of California Los Angeles, Awards-CEO of the .... Michel
Pébereau, France, CB-BNP Paribas, Compagnie de Saint-Gobain, Total, Banque Marocaine pour le Commerce et l'Industrie (BMCI) (Morocco), BNP Paribas SA (Switzerland), EADS N.V. (Netherlands), Pargesa Holding S.A. ...
Aug 15, 2008 by Kohzaki, K., Vingrys, A. J., Bui, B. V.
On the other hand, Kaneko et al.22 23 report no STR deficits in diabetic rats or humans. ... Blood glucose levels were measured at 1, 3, 9, and 12 weeks after STZ injection (Ascensia Esprit2 and Glucodisc; Bayer HealthCare, Pymble, NSW,
Australia), with levels >15 mmol/L indicative of diabetes. ... Luminous energy was calibrated using an integrating photometer (IL1700) with a filter (Z-CIE; International Light Technologies Inc., Newburyport, MA) and is specified in scotopic units.
Oct 4, 2010 by Benjamin Kramer
Claus Vogelmeier, David Ramos-Barbon, Damon Jack, Simon Piggott, Roger Owen, Mark Higgins, Benjamin Kramer* and INTIME study investigators (INdacaterol & TIotropium: Measuring Efficacy). * Corresponding ... 4 Novartis
Pharmaceuticals Inc., One Health Plaza, East Hanover, NJ 07936-1080, USA. For all author emails, ... 2010 Vogelmeier et al; licensee BioMed Central Ltd. This is an Open ..... ***p < 0.001 vs placebo; †p = 0.043 vs tiotropium. FEV1, forced ...
Sep 25, 2013 by masonblue
by Crane-Station cross posted at Firedoglake/MyFDL http://www.youtube.com/watch?v=xX5Ik_NvYKE In July of this year, The Supreme Court of the United States (SCOTUS) issued an Orwellian 5-4 opinion that shields generic drug
manufacturers from ... O's boss is big pharma. Lobbyists from Amgen, Bayer, Squib, et. al. were present for every major healthcare meeting & lobbyists often outright wrote the legislation and gave it to the administration. So no surprise.
Sep 13, 2013 by Kiyul Chung
Laurence Fink, US, CB- PNC Financial Services Group Inc., Innovir Laboratories Inc., York Stock Exchange, Inc., PE-The First Boston Corporation, VIMRx Pharmaceuticals Inc., E-University of California Los Angeles, Awards-CEO of ... Abdlatif Al-
Hamad, Kuwait, PD-Morgan Stanley, Marsh & McLennan Companies, Inc., American International Group, Inc., National Bank of Kuwait, PC-Arab Fund for Economic and Social Development, Arab Planning Institute, Banking ...